Search - tctmd.com

Displaying 1 - 20 of 408

Sort: Relevancy | Date

News Daily News

Meta-analysis Teases Out What Drives Success in M-TEER

Caitlin E. Cox

February 10, 2026

News Daily News

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Michael O'Riordan

January 22, 2026

News Daily News

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

Michael O'Riordan

December 30, 2025

News Daily News

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

Michael O'Riordan

December 23, 2025

Presentation TCT 2025

TCT 831: Role of Intraprocedural Hemodynamics to Predict Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair for Secondary MR

Presenter: Tyler Edward Klee

October 28, 2025

News Conference News TCT 2025

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

Todd Neale

October 27, 2025

Presentation TCT 2025

TCT 1473: Mitral TEER to Treat Severe MR After Dehisced Surgical Mitral Valve Annuloplasty Repair

Presenter: Anas Ibrahim Zaqut

October 27, 2025

Presentation TCT 2025

Mitral Valve-In-Ring Versus Redo-Surgery in MR Patients with Failed Surgical Valve Repair: Insights From The International Multi-Center REDO-MR Registry

Presenter: Guido Ascione

October 27, 2025

News Conference News ESC 2025

ESC/EACTS Release New Valvular Heart Disease Guidelines

Yael L. Maxwell

September 03, 2025

News Daily News

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

Caitlin E. Cox

August 13, 2025

News Daily News

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

L.A. McKeown

July 30, 2025

News Conference News NY Valves 2025

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Yael L. Maxwell

July 03, 2025

News Conference News NY Valves 2025

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Todd Neale

June 30, 2025

News Conference News NY Valves 2025

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Yael L. Maxwell

June 30, 2025

Presentation NY Valves 2025

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

Presenter: Fabio Sandoli de Brito

June 26, 2025

Presentation NY Valves 2025

MITRA-HR: TEER vs. Surgical Repair in High-Risk Patients

Presenter: Erwan Donal

June 25, 2025

Presentation NY Valves 2025

PRIMARY Trial: TEER vs. Surgical Repair in All-Comers

Presenter: Patrick T. O'Gara

June 25, 2025

Presentation NY Valves 2025

REPAIR-MR: TEER vs. Surgical Repair in Intermediate-Risk Patients

Presenter: Rahul Prakash Sharma

June 25, 2025

Presentation NY Valves 2025

The Reality of MR Recurrence After Surgical Mitral Valve Repair

Presenter: Vinayak N. Bapat

June 25, 2025

News Daily News

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Michael O'Riordan

May 28, 2025

Advertisement

Meta-analysis Teases Out What Drives Success in M-TEER

Worse TAVI and M-TEER Outcomes Seen With Low-Volume Operators

Year in Review: Tirzepatide, Finerenone, and Digitoxin Score Big in Heart Failure

FDA Approves Sapien M3 for Transseptal Mitral Valve Replacement

TCT 831: Role of Intraprocedural Hemodynamics to Predict Clinical Outcomes After Mitral Transcatheter Edge-to-Edge Repair for Secondary MR

ENCIRCLE: Good Results With Sapien M3 Transseptal TMVR

TCT 1473: Mitral TEER to Treat Severe MR After Dehisced Surgical Mitral Valve Annuloplasty Repair

Mitral Valve-In-Ring Versus Redo-Surgery in MR Patients with Failed Surgical Valve Repair: Insights From The International Multi-Center REDO-MR Registry

ESC/EACTS Release New Valvular Heart Disease Guidelines

TEER May Surpass Medical Therapy in High-risk Atrial FMR Patients

AF Touted as ‘Bad Player’ in Patients Undergoing Mitral TEER

MitraClip Safe and Effective in Non-COAPT-Like Patients: EXPANDed

Global Burden of Degenerative Mitral Valve Disease Continues to Rise

Good Outcomes, Little Hospital Experience: Pascal TEER in Real World

Posterior Leaflet Restoration to Reduce Secondary MR Using the MRace System (EXPLORE MR): Early Feasibility Experience (Polares)

MITRA-HR: TEER vs. Surgical Repair in High-Risk Patients

PRIMARY Trial: TEER vs. Surgical Repair in All-Comers

REPAIR-MR: TEER vs. Surgical Repair in Intermediate-Risk Patients

The Reality of MR Recurrence After Surgical Mitral Valve Repair

Tendyne Approved in US for High-risk Patients With Mitral Valve Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content